Abstract:Oxazinomycin is a C-nucleoside natural product
with antibacterial and antitumor activities. In addition to the characteristic C-glycosidic linkage shared with other C-nucleosides, oxazinomycin also features a structurally unusual 1,3-oxazine
moiety, the biosynthesis of which had previously been unknown. Herein,
complete in vitro reconstitution of the oxazinomycin biosynthetic
pathway is described. Construction of the C-glycosidic
bond between ribose 5-phosphate and an oxygen-labile pyridine heterocycle
is cata… Show more
“…194,195 The reaction of OzmD produces cyanide as a byproduct in addition to 163, as confirmed by a chemical derivatization method. 195 The released cyanide molecule originates from C3− NH 2 of 162, as verified by in vitro assays with 13 C-or 15 N-labeled substrates, which is in good agreement with an early feeding experiment with [2-14 C]-L-Glu. Furthermore, a series of 18 O labeling experiments indicated that the two carbonyl oxygens in 163 are retained during the OzmD-catalyzed reaction, while the alkoxy oxygen of 163 is derived from O 2 .…”
Section: C−c Bond Cleavage Reactionsmentioning
confidence: 77%
“…The unique pyridine base is derived from l -glutamine via the sugar-linked aminopyridine 162 as the intermediate. In vitro assays demonstrated that the unusual rearrangement reaction of 162 to 163 is catalyzed by OzmD. , …”
Section: Mononuclear Nonheme Iron Enzymesmentioning
confidence: 99%
“…Based on these observations, a plausible mechanism for the rearrangement reaction was proposed (Scheme B) . Although the oxidation state of iron during the reaction is unclear, it may bind to 162 and O 2 to initiate the catalysis.…”
Section: Mononuclear Nonheme Iron Enzymesmentioning
confidence: 99%
“…The sequence analysis revealed that OzmD exhibits similarity to GedK, as both enzymes are members of the DUF4243 family. 195 A structure prediction and mutagenesis study suggested that the four histidine residues in the active site, namely H30, H127, H268, and H352, are critical for the activity of OzmD, implying their roles in binding the iron for catalysis.…”
Section: C−c Bond Cleavage Reactionsmentioning
confidence: 99%
“…Based on these observations, a plausible mechanism for the rearrangement reaction was proposed (Scheme 19B). 195 Although the oxidation state of iron during the reaction is unclear, it may bind to 162 and O 2 to initiate the catalysis. The iron-mediated electron transfer from 164 to O 2 generates the semiquinone radical−Fe−superoxo species 165.…”
Nonheme iron-dependent enzymatic reactions play crucial
roles in
building and modifying bioactive organic molecules in all major classes
of natural product pathways. While the enzymes have evolved to use
a limited repertoire of protein folding and metal binding sites, the
oxidation reactions they catalyze are astonishingly diverse, spanning
from complex rearrangements to uncommon bond formation and cleavage
reactions. This review summarizes recent discoveries that have significantly
expanded our understanding of unusual nonheme iron enzyme catalysis
in natural product biosynthesis, covering the literature published
between 2017 and August 2022.
“…194,195 The reaction of OzmD produces cyanide as a byproduct in addition to 163, as confirmed by a chemical derivatization method. 195 The released cyanide molecule originates from C3− NH 2 of 162, as verified by in vitro assays with 13 C-or 15 N-labeled substrates, which is in good agreement with an early feeding experiment with [2-14 C]-L-Glu. Furthermore, a series of 18 O labeling experiments indicated that the two carbonyl oxygens in 163 are retained during the OzmD-catalyzed reaction, while the alkoxy oxygen of 163 is derived from O 2 .…”
Section: C−c Bond Cleavage Reactionsmentioning
confidence: 77%
“…The unique pyridine base is derived from l -glutamine via the sugar-linked aminopyridine 162 as the intermediate. In vitro assays demonstrated that the unusual rearrangement reaction of 162 to 163 is catalyzed by OzmD. , …”
Section: Mononuclear Nonheme Iron Enzymesmentioning
confidence: 99%
“…Based on these observations, a plausible mechanism for the rearrangement reaction was proposed (Scheme B) . Although the oxidation state of iron during the reaction is unclear, it may bind to 162 and O 2 to initiate the catalysis.…”
Section: Mononuclear Nonheme Iron Enzymesmentioning
confidence: 99%
“…The sequence analysis revealed that OzmD exhibits similarity to GedK, as both enzymes are members of the DUF4243 family. 195 A structure prediction and mutagenesis study suggested that the four histidine residues in the active site, namely H30, H127, H268, and H352, are critical for the activity of OzmD, implying their roles in binding the iron for catalysis.…”
Section: C−c Bond Cleavage Reactionsmentioning
confidence: 99%
“…Based on these observations, a plausible mechanism for the rearrangement reaction was proposed (Scheme 19B). 195 Although the oxidation state of iron during the reaction is unclear, it may bind to 162 and O 2 to initiate the catalysis. The iron-mediated electron transfer from 164 to O 2 generates the semiquinone radical−Fe−superoxo species 165.…”
Nonheme iron-dependent enzymatic reactions play crucial
roles in
building and modifying bioactive organic molecules in all major classes
of natural product pathways. While the enzymes have evolved to use
a limited repertoire of protein folding and metal binding sites, the
oxidation reactions they catalyze are astonishingly diverse, spanning
from complex rearrangements to uncommon bond formation and cleavage
reactions. This review summarizes recent discoveries that have significantly
expanded our understanding of unusual nonheme iron enzyme catalysis
in natural product biosynthesis, covering the literature published
between 2017 and August 2022.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.